Journal of Neurology

, Volume 252, Issue 10, pp 1279–1279 | Cite as

Transcatheter patent foramen ovale closure

Identifying the ideal candidate according to the available evidence


  1. 1.
    Ago T, Ooboshi H, Kitazono T, et al. (2004) Brain infarction associated with antiphospholipid antibody syndrome caused by paradoxical embolism through patent foramen ovale. J Neurol 251:757–759CrossRefPubMedGoogle Scholar
  2. 2.
    Thomas HR (2001) Hypercoagulability syndromes. Arch Intern Med 161:2433–2439CrossRefPubMedGoogle Scholar
  3. 3.
    Chaturvedi S (1998) Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale. J Neurol Sci 160:158–160CrossRefPubMedGoogle Scholar
  4. 4.
    Mohr JP, Thompson JLP, Lazar RM, et al. (2001) A Comparison ofWarfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke. N Engl J Med 345:1444–1451CrossRefPubMedGoogle Scholar
  5. 5.
    Windecker S, Wahl A, Nedeltchev K, et al. (2004) Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 44:750–758CrossRefPubMedGoogle Scholar
  6. 6.
    Giardini A, Donti A, Formigari R, et al. (2004) Comparison of Results of Percutaneous Closure of Patent Foramen Ovale for Paradoxical Embolism in Patients With-vs-Without Thrombophilia. Am J Cardiol 94:1012–1016CrossRefPubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2005

Authors and Affiliations

  1. 1.Pediatric Cardiology and Adult Congenital UnitUniversity of BolognaBolognaItaly

Personalised recommendations